Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Buttò

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Experimental Medicine|July 1, 1991
Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chainsF Grassi, R Meneveri, M Gullberg, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individualsG B Rossi, P Verani, B Macchi, et al.
Journal of Clinical Microbiology|March 1, 1995
Direct detection of proviral gag segment of human immunodeficiency virus in peripheral blood lymphocytes by colorimetric PCR assay as a clinical laboratory tool applied to different at-risk populationsF Pane, S Buttò, M L Gobbo, et al.
International Journal of Cancer|July 15, 1998
Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infectionsG Rezza, E T Lennette, M Giuliani, et al.
Molecular Biology of the Cell|October 13, 2001
Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factorE Toschi, G Barillari, C Sgadari, et al.
Vaccine|February 9, 2011
Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trialL Gudmundsdotter, B Wahren, B K Haller, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Vaccine|April 3, 2001
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)A Cafaro, F Titti, C Fracasso, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Experimental Medicine|July 1, 1991
Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chainsF Grassi, R Meneveri, M Gullberg, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individualsG B Rossi, P Verani, B Macchi, et al.
Journal of Clinical Microbiology|March 1, 1995
Direct detection of proviral gag segment of human immunodeficiency virus in peripheral blood lymphocytes by colorimetric PCR assay as a clinical laboratory tool applied to different at-risk populationsF Pane, S Buttò, M L Gobbo, et al.
International Journal of Cancer|July 15, 1998
Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infectionsG Rezza, E T Lennette, M Giuliani, et al.
Molecular Biology of the Cell|October 13, 2001
Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factorE Toschi, G Barillari, C Sgadari, et al.
Vaccine|February 9, 2011
Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trialL Gudmundsdotter, B Wahren, B K Haller, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Vaccine|April 3, 2001
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)A Cafaro, F Titti, C Fracasso, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Pageof 3